chronic insomnia
Conditions
Interventions
Benzodiazepine sleeping pills (BZDs): None
other types:None
Sponsors
Chengdu Fifth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Male or female aged 18 to 70; (2) Consistent with the diagnosis of chronic insomnia; (3) Continuous use of benzodiazepines (BZDs) for more than one month, or more than three times a week for more than three consecutive months.
Exclusion criteria
Exclusion criteria: (1) Primary school education or below; (2) Inability to understand and cooperate; (3) Combined with schizophrenia and bipolar disorder. (4) The comprehensive treatment methods meet the project standards for less than 3 items. Such as severe coagulation dysfunction, severe cardiovascular diseases, shock state, elevated intracranial pressure or intracranial space-occupying lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction rate of sleeping pills; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleeping pill tapering rate (at other times);Insomnia Severity Index;Patient Health Questionnaire-9;Generalized Anxiety Disorder Scale;Benzodiazepine Withdrawal Symptom Questionnaire;somatic symptom scale; | — |
Countries
China
Contacts
Public ContactYin Hong
Chengdu Fifth People's Hospital
Outcome results
None listed